In a study published in the journal Nature Reviews Drug Discovery last week, a group of Harvard Medical School researchers found that early trials of certain central nervous system drugs weren’t very predictive of whether the drugs ultimately worked. Aaron Kesselheim (Brigham and Women’s) led the research.
